Ophiopogonin D mitigates doxorubicin-induced cardiomyocyte ferroptosis through the β-catenin/GPX4 pathway

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-05-23
DOI
https://doi.org/10.3389/fphar.2025.1586937
Citations
2
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
3.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ophiopogonin D mitigates doxorubicin-induced cardiomyocyte ferroptosis through the β-catenin/GPX4 pathway

Yanping Lei, Liangliang Xu, Rui Liu, Yue Zhao
2 citations
Frontiers in Pharmacology
Ferroptosis and cancer prognosis
3.04
article

Ophiopogonin D mitigates doxorubicin-induced cardiomyocyte ferroptosis through the β-catenin/GPX4 pathway

Yanping Lei, Liangliang Xu, Rui Liu, Yue Zhao
article en
2 citations

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 16
University of South China (CN)
Good health and well-being
Openalex Percentile: Top 9%
Ferroptosis and cancer prognosis
3.04
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Ophiopogonin D mitigates doxorubicin-induced cardiomyocyte ferroptosis through the β-catenin/GPX4 pathway — Yanping Lei, Liangliang Xu, et al. · Frontiers in Pharmacology (2025) | TGRS Research Map | TGRS